Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

World-leading researchers from the UK Pandemic Ethics Accelerator Collaborative consider - how we should evaluate decisions made during the covid-19 pandemic and the future response to pandemic threats.

Professor Ilina Singh, the Ethics Accelerator's Principal Investigator, and PI in the Department of Psychiatry, and Co-Director of the Wellcome Centre for Ethics & Humanities at the University of Oxford, said:

'We are going to have to learn how to live with covid-19. The work of the Ethics Accelerator facilitates grappling with the hard decisions through clear-sighted analysis of what is gained and lost in decisions and choices made individually and collectively. As a society, we all will still need to make trade-offs to suppress the virus in the long term. Those decisions will affect us all. For example, the measures to reduce deaths and protect health services have created risks and impacts elsewhere, including increased waiting list times and people becoming reluctant to seek medical help, as well as impacts on mental health, child development and education.

'In terms of mortality, the pandemic is now forcing us to consider what sorts of deaths, and whose deaths should we be most concerned about, as well as the values that underpin such judgments. Untimely or unexpected deaths are something to be avoided – but at what cost?'

'In considering many of these issues, the approach by government has often been top-down. At the heart of future policies informing the covid-19 recovery must lie serious and genuine attempts to engage a range of perspectives, including the wider public in identifying what is important to them. Understanding how publics judge and respond to risks, and the diverse values that influence these judgments, is crucial in shaping effective and ethical pandemic policy.'

The pandemic has seen not only the tragic deaths caused directly by the virus – 130,000 in the UK and the 3 million worldwide – but also the illness caused by long-covid.

There have been indirect impacts on health too, due to postponed treatments, and to people avoiding health and care systems, leading to delayed diagnosis and treatment. There have also been mental health impacts, resulting from anxiety, loneliness and isolation. We are going to be living with the wider impacts of covid-19 for a long time and we need to consider what priorities and values should guide us through this next phase and into the future.

A series of thought provoking articles has been written, entitled Living and dying with covid:

For more information on the UK Pandemic Ethics Accelerator and to follow on twitter @PandemicEthics_.

Similar stories

Viewing self-harm images on the internet and in social media usually causes harm, according to new review

Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.

Can humans hibernate?

Illuminating new TEDx Talk from Professor of Sleep Physiology Vladyslav Vyazovskiy

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

New insights into chemogenetic designer drugs to enhance our study of behaviour

A collaborative team of researchers in DPAG and Pharmacology led by Dr Lukas Krone have uncovered striking new data demonstrating that two widely used designer drugs used to turn populations of neurons on and off in the brain cause unexpected effects on sleep. These results demonstrate a critical need to improve chemogenetic approaches in behavioural studies.

Researchers win UK Dementia Research Institute Grand Challenge Award to identify early signs of Alzheimer's

The MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.

Ensuring LGBTQI+ people are treated fairly in mental health data

Andrey Kormilitzin outlines a new participatory study aimed at improving AI to take account of LGBTQI+ people so that their needs are better met by mental health services.